Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey

AIM: This review summarizes current data on Rho-kinase (ROCK) inhibitors use in ocular diseases, primarily glaucoma. BACKGROUND: Translational research over the last decade culminating in the development of ROCK inhibitors has provided a much-needed shot in the arm to glaucoma pharmacopeia. ROCK pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kirti, Singh, Arshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203326/
https://www.ncbi.nlm.nih.gov/pubmed/37228304
http://dx.doi.org/10.5005/jp-journals-10078-1396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203326/
https://www.ncbi.nlm.nih.gov/pubmed/37228304
http://dx.doi.org/10.5005/jp-journals-10078-1396

Ejemplares similares